117 related articles for article (PubMed ID: 9880242)
1. The 11th conference on hemoglobin switching. Orcas Island, Washington, USA. October 2-6, 1998. Abstracts.
Blood Cells Mol Dis; 1998 Dec; 24(4):462-521. PubMed ID: 9880242
[No Abstract] [Full Text] [Related]
2. The impact of molecular biology on the diagnosis and treatment of hemoglobin disorders.
Berg PE; Schechter AN
Mol Genet Med; 1992; 2():1-38. PubMed ID: 1458221
[No Abstract] [Full Text] [Related]
3. 12th Conference on Hemoglobin Switching. Orcas Island, Washington, USA. Abstracts.
Blood Cells Mol Dis; 2000 Oct; 26(5):490-533. PubMed ID: 11191215
[No Abstract] [Full Text] [Related]
4. Gene therapy for the hemoglobin disorders: past, present, and future.
Persons DA; Nienhuis AW
Proc Natl Acad Sci U S A; 2000 May; 97(10):5022-4. PubMed ID: 10805762
[No Abstract] [Full Text] [Related]
5. Lenti in red: progress in gene therapy for human hemoglobinopathies.
von Kalle C; Baum C; Williams DA
J Clin Invest; 2004 Oct; 114(7):889-91. PubMed ID: 15467825
[TBL] [Abstract][Full Text] [Related]
6. An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference.
Blobel GA; Bodine D; Brand M; Crispino J; de Bruijn MF; Nathan D; Papayannopoulou T; Porcher C; Strouboulis J; Zon L; Higgs DR; Stamatoyannopoulos G; Engel JD
Exp Hematol; 2015 Oct; 43(10):821-37. PubMed ID: 26143582
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic manipulation of globin gene expression in the hemoglobinopathies.
Johnson CS
J Natl Med Assoc; 1986 Jul; 78(7):599-600. PubMed ID: 3746928
[No Abstract] [Full Text] [Related]
8. The molecular genetics of human hemoglobins.
Maniatis T; Fritsch EF; Lauer J; Lawn RM
Annu Rev Genet; 1980; 14():145-78. PubMed ID: 6452087
[No Abstract] [Full Text] [Related]
9. Molecular biologic diagnosis of the hemoglobinopathies.
Schwartz E; Surrey S
Hosp Pract (Off Ed); 1986 Sep; 21(9):163-78. PubMed ID: 3091617
[No Abstract] [Full Text] [Related]
10. Globin gene expression and hematopoietic differentiation. Proceedings of the Third Conference on Hemoglobin Switching. September 12-15, 1982.
Prog Clin Biol Res; 1983; 134():1-544. PubMed ID: 6664993
[No Abstract] [Full Text] [Related]
11. Developmental biology of human hemoglobins.
Wood WG; Clegg JB; Weatherall DJ
Prog Hematol; 1977; 10():43-90. PubMed ID: 337366
[No Abstract] [Full Text] [Related]
12. Gene Therapy Approaches to Hemoglobinopathies.
Ferrari G; Cavazzana M; Mavilio F
Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
[TBL] [Abstract][Full Text] [Related]
13. Prospects of gene therapy for hemoglobinopathies.
Steinberg MH
Am J Med Sci; 1991 Nov; 302(5):298-303. PubMed ID: 1750450
[TBL] [Abstract][Full Text] [Related]
14. The effect of alpha-hemoglobin gene deletions on the red blood cells' mean cell volume and hemoglobin levels.
Thompson CC; Houston DS; Boyadjian S; Ali MA
J Lab Clin Med; 1990 Oct; 116(4):573-4. PubMed ID: 2212864
[No Abstract] [Full Text] [Related]
15. [Structure of the globin genes in persons with anomalous hemoglobins].
Kavsan VM
Tsitol Genet; 1982; 16(2):62-72. PubMed ID: 6179278
[No Abstract] [Full Text] [Related]
16. Recent advance on genome editing for therapy of β-hemoglobinopathies.
Liu JW; Hong T; Qin X; Liang YM; Zhang P
Yi Chuan; 2018 Feb; 40(2):95-103. PubMed ID: 29428902
[TBL] [Abstract][Full Text] [Related]
17. Impact of epigenetic mechanisms on therapeutic approaches of hemoglobinopathies.
Costa D; Capuano M; Sommese L; Napoli C
Blood Cells Mol Dis; 2015 Aug; 55(2):95-100. PubMed ID: 26142322
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygosity of non-deletional hereditary persistence of fetal hemoglobin and deltabeta-thalassemia.
Kalamaras A; Chassanidis C; Samara M; Papadakis MN; Vagena A; Aleporou-Marinou V; Patrinos GP; Kollia P
Am J Hematol; 2008 Sep; 83(9):760. PubMed ID: 18615450
[No Abstract] [Full Text] [Related]
19. Globins, from Genes to Physiology and Diseases.
Vernimmen D
Blood Cells Mol Dis; 2018 May; 70():1. PubMed ID: 28214138
[No Abstract] [Full Text] [Related]
20. Hemoglobin Bart's disease in an Italian boy. Interaction between alpha-thalassemia and hereditary persistence of fetal hemoglobin.
Chui DH; Patterson M; Dowling CE; Kazazian HH; Kendall AG
N Engl J Med; 1990 Jul; 323(3):179-82. PubMed ID: 1694572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
